Evolving role of patient associations in shaping healthcare policies in Brazil
Main Article Content
Abstract
Patient associations are civil society organizations that play a key role in supporting individuals undergoing long-term health treatments, particularly in developing countries. Most of them are also actively involved in defending patients' rights through initiatives that aim to develop and implement public policies focused on supporting care. Patient associations have grown increasingly professionalized, driven by serious issues regarding healthcare access and outcomes, especially in critical areas like oncology. In this article, we explore the evolving role of patient associations in the formulation of national health policies based on advocacy actions promoted by the Brazilian Federation of Philanthropic Institutions for the Support of Breast Health (FEMAMA), a civil society organization with over 19 years of experience and the biggest network of patient associations in the country, with more than 70 associates. FEMAMA is aligned with national medical societies and international guidelines, such as the World Health Organization's Global Breast Cancer Initiative and the Union for International Cancer Control, which aims to reduce the global burden of breast cancer through collaboration and strengthened health systems. Civil society mobilizations promoted by FEMAMA over the years have contributed to the implementation of structural public health policies, both for public and private health systems in Brazil. Initially focused on breast cancer, some of these achievements were later expanded to oncology as a whole, particularly benefiting patients relying on the public health system, which is the only healthcare access option for 71.5% of Brazilians. Over the years, patient associations have significantly influenced advances in oncology and general health public policy. However, advocacy is a continuous work, with goals that evolve alongside clinical, systemic, and socio-political developments.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
https://doi.org/10.1016/j.breast.2011.02.005.
2. Caleffi M, Hobold EA, Johnson G. The Relevant Work of Breast Cancer Patient Associations in the Search for Quality Access to Care and Guarantee of Rights in Brazil. Curr Breast Cancer Rep. 2023; 15:1-6. https://doi.org/10.1007/s12609-023-00496-0.
3. Albuquerque A, Soares Neto JAR. Patient organizations and their role in implementing health care rights. Ibero-American Health Law Notebooks. 2022;11(1):144-162. https://doi.org/10.17566/ciads.v11i1.811.
4. Caleffi M, et al. Breast cancer survival in Brazil: How much does health care access impact cancer outcomes? Breast. 2020;54:155-159. https://doi.org/10.1016/j.breast.2020.10.001.
5. Brazilian Federation of Philanthropic Institutions Supporting Breast Health (FEMAMA). Available at: https://femama.org.br/. Accessed May 2025.
6. World Health Organization (WHO). Global Breast Cancer Initiative Implementation Framework: Assessing, Strengthening and Scaling-Up of Services for the Early Detection and Management of Breast Cancer. Geneva: WHO; 2023. Available at:
https://www.who.int/initiatives/global-breast-cancer-initiative/. Accessed May 2025.
7. Union for International Cancer Control (UICC). Breast Cancer Advocacy Handbook: A Handbook to Support and Inspire Cancer Advocates. Geneva; 2024. Available at: https://www.uicc.org/news-and-updates/resources/breast-cancer-advocacy-handbook. Accessed May 2025.
8. World Health Organization (WHO). Breast Cancer. Available at: https://www.who.int/news-room/fact-sheets/detail/breast-cancer. Accessed May 2025.
9. Brazilian Institute of Geography and Statistics (IBGE). National Health Survey: 2019: Life Cycles. Rio de Janeiro: IBGE; 2021.
10. Brazil. Federal Law 11664, April 29, 2008. Provides for health actions to ensure prevention, detection, treatment, and follow-up of cervical and breast cancers within the Unified Health System (SUS). Brasília, 2008.
11. Brazil. Federal Law 12732, November 22, 2012. Provides for the first treatment of patients with confirmed malignant neoplasia and establishes a timeframe for its initiation. Brasília, 2012.
12. Brazil. Federal Law 13685, June 25, 2018. Provides for mandatory reporting of health conditions and events related to neoplasms and congenital malformations. Brasília, 2018.
13. Gomes AL et al. Inclusion of Metastatic Breast Cancer Treatments in SUS (Public Health Care System): Strategic Actions. Journal of Global Oncology. 2018; 4(2): 151. https://doi.org/10.1200/jgo.18.71300.
14. Brazil. Federal Law 14758, December 19, 2023. Establishes the National Policy for Cancer Prevention and Control and the National Navigation Program for People Diagnosed with Cancer within the SUS. Brasília, 2023.
15. FEMAMA. PCDT Rosa. Available at:
https://femama.org.br/site/pcdt-rosa/. Accessed May 2025.
16. Ministry of Health (Brazil). National Committee for Health Technology Incorporation (Conitec). Clinical Protocol and Therapeutic Guidelines: Breast Cancer. 2024.
17. FEMAMA. Pay More Attention, She Needs It (#elaprecisa). Available at:
https://demaisatencao.femama.org.br/. Accessed May 2025.
18. Ministry of Health (Brazil). Ordinance SCTIE/MS No. 73, December 6, 2021. Establishes the incorporation of medications (abemaciclib, palbociclib, and ribociclib succinate) for the treatment of advanced or metastatic hormone receptor-positive (HR+) and HER2-negative breast cancer within SUS. Diário Oficial da União, Section 1. December 7, 2021.
19. Brazilian College of Radiology and Diagnostic Imaging (CBR), Brazilian Society of Mastology (SBM), the Brazilian Federation of Gynecology and Obstetrics Associations (FEBRASGO), Brazilian Society of Clinical Oncology (SBOC), the Brazilian Society of Radiotherapy (SBRT), the Federal Council of Medicine (CFM), Brazilian Federation of Philanthropic Institutions Supporting Breast Health (FEMAMA), Oncoguia. Technical Scientific Opinion on the importance of starting mammographic screening at age 40 and over 70 for early detection of breast cancer. Available at: https://cbr.org.br/wp-content/uploads/2025/02/Parecer_reuniao_ANS_contribuicoes_-CBR-SBM-FEBRASGO-FEMAMA_v-final.pdf. Accessed May 2025.
20. Ministry of Health (Brazil). National Health Supplement Agency. Public Consultation - CP N. 144, which institutes the Certification Program for Good Practices in Health Care for Private Health Care Plan Operators, containing the Certification Manual for Good Practices in Oncological Care - OncoRede. Available at:
https://www.gov.br/ans/pt-br/acesso-a-informacao/participacao-da-sociedade/consultas-publicas/consulta-publica-144. Accessed May 2025.
21. National Cancer Institute (INCA). Breast Cancer Control in Brazil: Data and Numbers. Rio de Janeiro: INCA; 2024. Available at:
https://www.inca.gov.br/publicacoes/livros/controle-do-cancer-de-mama-no-brasil-dados-e-numeros-2024. Accessed May 2025.
22. Almeida, A, Rosenburg, J. Overview of breast cancer care in the Brazilian Unified Health System (SUS). Observatório de Oncologia. 2023. Available at: https://observatoriodeoncologia.com.br/estudos/outros/cancer-de-mama/2023/panorama-da-atencao-ao-cancer-de-mama-no-sus-2/. Accessed May 2025.
23. Rosa DD, et al. The impact of sociodemographic factors and health insurance coverage on the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115). Breast Cancer Res Treat. 2020. https://doi.org/10.1007/s10549-020-05831-y.
24. Chhetri D, Zacarias F. Advocacy for Evidence-Based Policy-Making in Public Health: Experiences and the Way Forward. J Health Manag. 2021; 23(1): 85-94. https://doi.org/10.1177/0972063421994948.
25. Dall’Agnol CF, et al. Transparency and accountability in resource mobilization in the third sector: a multiple case study conducted in Southern Brazil. Universo Contábil. 2017;13(2):187-203. Available at:
https://www.redalyc.org/pdf/1170/117051921011.pdf. Accessed May 2025.
26. Mutebi M, et al. Breast cancer treatment: A phased approach to implementation. Cancer. 2020; 126:2365-2378. https://doi.org/10.1002/cncr.32910.